(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Life Science Industry Banner - Advancing Healthcare Solutions
Mouse Scroll Icon
August 2020

Tom Loewald joins Cambrex’ Board of Directors as new CEO

CDMO Cambrex announced the appointment of Tom Loewald to their Board of Directors, effective September 7, 2020. Tom is a 15-year veteran of Thermo Fisher Scientific and is currently the President of the Flexibles Division at ProAmpac.

Tom will be taking over his duties as the Chief Executive Officer from September 7, 2020.

Cambrex Corporation is a Contract Development Manufacturing Organization that provides drug substance, drug product, and analytical services across the entire drug lifecycle, as well as active pharmaceutical ingredients. Cambrex has cGMP manufacturing facilities in the US, Canada and Europe. They are a 534.7 million USD company headquartered in New Jersey, United States, with over 2100 employees.